Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (281-290 of 662) with videos related to

Pageof 67
Sort By:
Cancer|October 14, 2006
Neoplastic stem cells: a novel therapeutic target in clinical oncologyAxel Schulenburg, Herbert Ulrich-Pur, Dietmar Thurnher, et al.
Veterinary Immunology and Immunopathology|June 10, 2009
Growth-inhibitory effects of four tyrosine kinase inhibitors on neoplastic feline mast cells exhibiting a Kit exon 8 ITD mutationEmir Hadzijusufovic, Barbara Peter, Laura Rebuzzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantationWolfgang R Sperr, Johannes Drach, Alexander W Hauswirth, et al.
International Journal of Clinical and Health Psychology : IJCHP|June 6, 2022
Latent structure and measurement invariance of the Hospital Anxiety and Depression Scale in cancer outpatientsElisabeth L Zeilinger, Ingo W Nader, Wolfgang Wiedermann, et al.
Leukemia & Lymphoma|May 11, 2002
Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteriaJohn-Hendrik Jordan, Gerit-Holger Schernthaner, Robert Fritsche-Polanz, et al.
Veterinary and Comparative Oncology|April 12, 2017
The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytomaAlexandra Keller, Bettina Wingelhofer, Barbara Peter, et al.
Haematologica|July 7, 2018
Preclinical human models and emerging therapeutics for advanced systemic mastocytosisMichel Arock, Ghaith Wedeh, Gregor Hoermann, et al.
The Journal of Allergy and Clinical Immunology|August 4, 2014
Familial hypertryptasemia with associated mast cell activation syndromeVito Sabato, Els Van De Vijver, Margo Hagendorens, et al.
Plos One|February 4, 2014
Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-RIrina Mirkina, Emir Hadzijusufovic, Clemens Krepler, et al.
Neoplasia (New York, N.Y.)|August 21, 2012
Identification of basophils as a major source of hepatocyte growth factor in chronic myeloid leukemia: a novel mechanism of BCR-ABL1-independent disease progressionSabine Cerny-Reiterer, Viviane Ghanim, Gregor Hoermann, et al.
Pageof 67

Showing results (281-290 of 662) with videos related to

Sort By:
Pageof 67
Cancer|October 14, 2006
Neoplastic stem cells: a novel therapeutic target in clinical oncologyAxel Schulenburg, Herbert Ulrich-Pur, Dietmar Thurnher, et al.
Veterinary Immunology and Immunopathology|June 10, 2009
Growth-inhibitory effects of four tyrosine kinase inhibitors on neoplastic feline mast cells exhibiting a Kit exon 8 ITD mutationEmir Hadzijusufovic, Barbara Peter, Laura Rebuzzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantationWolfgang R Sperr, Johannes Drach, Alexander W Hauswirth, et al.
International Journal of Clinical and Health Psychology : IJCHP|June 6, 2022
Latent structure and measurement invariance of the Hospital Anxiety and Depression Scale in cancer outpatientsElisabeth L Zeilinger, Ingo W Nader, Wolfgang Wiedermann, et al.
Leukemia & Lymphoma|May 11, 2002
Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteriaJohn-Hendrik Jordan, Gerit-Holger Schernthaner, Robert Fritsche-Polanz, et al.
Veterinary and Comparative Oncology|April 12, 2017
The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytomaAlexandra Keller, Bettina Wingelhofer, Barbara Peter, et al.
Haematologica|July 7, 2018
Preclinical human models and emerging therapeutics for advanced systemic mastocytosisMichel Arock, Ghaith Wedeh, Gregor Hoermann, et al.
The Journal of Allergy and Clinical Immunology|August 4, 2014
Familial hypertryptasemia with associated mast cell activation syndromeVito Sabato, Els Van De Vijver, Margo Hagendorens, et al.
Plos One|February 4, 2014
Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-RIrina Mirkina, Emir Hadzijusufovic, Clemens Krepler, et al.
Neoplasia (New York, N.Y.)|August 21, 2012
Identification of basophils as a major source of hepatocyte growth factor in chronic myeloid leukemia: a novel mechanism of BCR-ABL1-independent disease progressionSabine Cerny-Reiterer, Viviane Ghanim, Gregor Hoermann, et al.
Pageof 67